Related Experiment Video
Updated: Oct 9, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Management of Isolated, Congenital Anterior Mitral Valve Cleft
J Blade Hargiss1, Joseph A Dearani2, Elizabeth H Stephens2
14352Mayo Clinic Alix School of Medicine, Rochester, MN, USA.
Insights
Surgical repair of isolated anterior mitral valve clefts (MVC) is safe and effective, leading to low rates of mitral regurgitation. Intervention decisions should prioritize symptom severity and mitral regurgitation grade over MVC presence alone.
Area of Science:
- Cardiology
- Congenital Heart Disease
- Cardiac Surgery
Background:
- Isolated anterior mitral valve clefts (MVC) are rare congenital heart defects.
- Limited data exist on the natural history and surgical outcomes of isolated MVCs.
Purpose of the Study:
- To evaluate the natural history and surgical outcomes of isolated congenital mitral valve clefts.
- To determine the safety and efficacy of surgical repair for isolated MVCs.
Main Methods:
- Retrospective review of patients with congenital MVC evaluated at Mayo Clinic (1993-2020).
- Patients divided into surgical repair and non-surgical cohorts.
- Analysis of baseline and postoperative clinical and echocardiographic data.
Main Results:
- Eight patients underwent surgical repair (median MR grade 1 post-op, stable at follow-up).
- Fourteen patients were in the non-surgical cohort (all asymptomatic, median MR grade 1).
- Surgical repair via sternotomy or minimally invasive approaches was safe and effective.
Conclusions:
- Mitral valve cleft repair is safe, successful, and associated with low recurrence of mitral valve dysfunction.
- Durable surgical repair of isolated congenital MVC is feasible in select patients.
- Intervention should be guided by mitral regurgitation severity and symptoms, not solely by MVC presence.
Abstract:
Background: Isolated anterior mitral valve clefts (MVC) are rare congenital heart defects, and data are limited regarding the natural history and surgical outcomes for such isolated MVCs. Methods: We conducted a retrospective review of patients with congenital MVC who were evaluated at Mayo Clinic in Rochester, Minnesota between 1993 and 2020. Patients were separated into two cohorts: those who underwent surgical repair of the MVC and those who had not yet undergone repair. Baseline and postoperative clinical and echocardiographic data were analyzed. Results: Fourteen patients were included in the nonsurgical cohort and eight patients in the surgical cohort. Surgical repair was via primary median sternotomy (n = 6) or robot-assisted, minimally invasive (n = 2). All cleft repairs were performed by simple suture closure. Intraoperative evaluation of the clefts did not reveal additional structural factors that could account for the mitral regurgitation (MR). At latest follow-up of the surgical cohort, the median grade of MR was 1 (range 0-1), and median left ventricular ejection fraction was 65% (IQR 59%-67%), both similar to the immediate postoperative result. At latest follow-up, all patients in the nonsurgical cohort were NYHA Class 1, and median MR grade was 1. All patients were asymptomatic (NYHA Class 1). Conclusions: Our findings corroborate prior reports that MVC repair is safe and successful and is followed by a low rate of recurrent mitral valve dysfunction. Durable surgical repair of isolated, congenital MVC can be performed safely in select patients. The decision to intervene should be based on the severity of mitral regurgitation and patient symptoms rather than the presence of the MVC alone.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis IV: Nursing Management

